In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands.
about
Between Adamantane and Atrane: Intrabridgehead Interactions in the Cage-Like Phosphane Related to a Novel Tris(homoadamantane) Ring System.Data-driven high-throughput prediction of the 3-D structure of small molecules: review and progress.Tuning heavy metal compounds for anti-tumor activity: is diversity the key to ruthenium's success?Targeted and multifunctional arene ruthenium chemotherapeutics.Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs.Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexesRemarkable enhancement in photocytotoxicity and hydrolytic stability of curcumin on binding to an oxovanadium(IV) moiety.Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity.Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.Zinc(II) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells.Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.Effect of amide-triazole linkers on the electrochemical and biological properties of ferrocene-carbohydrate conjugates.Arene ruthenium complexes as anticancer agents.Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.New [(η(5)-C5H5)Ru(N-N)(PPh3)][PF6] compounds: colon anticancer activity and GLUT-mediated cellular uptake of carbohydrate-appended complexes.Metal Complexation of a D-Ribose-Based Ligand Decoded by Experimental and Theoretical StudiesAnticancer Activities of Mononuclear Ruthenium(II) Coordination Complexes
P2860
Q31121936-65BCC790-9D71-4E5E-8EAC-F937B81F58E3Q33850046-C0E24843-7D1E-440B-8A6C-A735F782515BQ37855894-E161F72C-9803-40A4-9590-FB7C07AB84A0Q37920741-7D8E84B1-DCBD-4251-9496-6BBB3A145172Q38105454-8AECA7A7-777D-49FB-A39E-1380946E2CC6Q38693266-2C6792EF-D416-4C72-BA01-C225C6C42DDCQ38916295-C3B955ED-ECA3-4F72-8C80-6985E66DBF88Q38939454-76A09B39-F2F7-4A44-8D12-DF1A0BAF510BQ39177371-0C1FAFE7-DD35-4CFA-8462-50F58A7F002AQ39178846-4871241A-F010-4EC8-B539-EA2F5CC5923AQ39184979-4EE25E4E-FA63-496D-BCCA-0794F8F02DF0Q39206559-06D52F53-AA17-4836-9BD7-9404112D4598Q39229950-2EB97740-A42A-4212-A84F-671380188E66Q39251297-94F4AF9B-D5B8-4DCE-B3B0-8B73CEC587BFQ39706669-F7FDD8E2-10EA-4037-BEF8-A22725EDDBE5Q39788647-74BBBB98-8D79-4FBE-9F22-2BD99801F068Q46256422-328206AF-F35D-486F-B020-B786399D0212Q46468084-171014B8-D149-4AE3-9EFB-A4A1A652CA54Q49687144-0AE38433-0958-4C99-95A5-114860569938Q53095820-7D85D048-4C07-4B03-A17D-27E175FA0F58Q58571747-250184D4-EF65-483E-AF3D-8C645C37C75BQ59101621-9831AF8C-1738-45BD-8FC3-802EC32A0AF8
P2860
In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
In vitro anticancer activity a ...... th carbohydrate-based ligands.
@en
In vitro anticancer activity a ...... th carbohydrate-based ligands.
@nl
type
label
In vitro anticancer activity a ...... th carbohydrate-based ligands.
@en
In vitro anticancer activity a ...... th carbohydrate-based ligands.
@nl
prefLabel
In vitro anticancer activity a ...... th carbohydrate-based ligands.
@en
In vitro anticancer activity a ...... th carbohydrate-based ligands.
@nl
P2093
P2860
P50
P356
P1476
In vitro anticancer activity a ...... th carbohydrate-based ligands.
@en
P2093
Florian Biba
Frederic Schmitt
Isabella Berger
Lucienne Juillerat-Jeanneret
Markus Galanski
Olivier Zava
Roland O John
Vladimir B Arion
P2860
P304
P356
10.1002/CHEM.200801032
P407
P50
P577
2008-01-01T00:00:00Z